...of new drugs in dermatology caused in part by large pharmas like Allergan plc and Valeant...
...Sciences Inc., where Chaudhuri was president and CEO. Chaudhuri continued to served as president of Valeant...

...Center for Molecular Medicine (C3M) and Rachid Benhida of the Institute of Chemistry of Nice (ICN...

...a $650 million follow-on. Were it not for 2017’s $6.5 billion in notes deals by Valeant...

...Next steps could include investigating the mechanism by which brain lymphatic vessels contribute to MS. Valeant...

...potassium channel modulator in development to treat epilepsy, from Bausch Health Companies Inc. (NYSE:BHC; formerly Valeant...

...potassium channel modulator in development to treat epilepsy, from Bausch Health Companies Inc. (NYSE:BHC; formerly Valeant...

...least 8 profitable biotechs and pharmas are slated to report earnings this week. (A) Formerly Valeant...

...period was aided by $3.8 billion in M&A-related equity raises by Endo International plc and Valeant...
...Ltd. (HKSE:1833), Shanghai, China Shenogen Pharma Group Ltd. Beijing, China State Drug Administration, Beijing, China Valeant...
...Co. Endo International plc I-Mab Biopharma Innovent Biologics Inc. Madrigal Pharmaceuticals Inc. Novavax Inc. Pfizer Inc. Ping An Healthcare and Technology Co. Ltd. Valeant...

...a complete response letter for Furoscix (scFurosemide) to treat edema in patients with heart failure Valeant...

...acid (ETC-1002) / ezetimibe ASCVD Top-line Ph III data August EyeGate Pharmaceuticals Inc. (NASDAQ:EYEG) / Valeant...
...NASDAQ:URGN) MitoGel (UGN-101) Low-grade upper tract urothelial carcinoma (UTUC) Top-line Ph III OLYMPUS data 2H18 Valeant...